Mirago S 50 Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Mirabegron (50mg) + Solifenacin (5mg)
Overview Mirago S 50 Tablet ER
Urinary relief is provided by Mirago S 50 Extended-Release tablets, a dual-action formulation addressing overactive bladder symptoms. This medication alleviates frequent urination, urgency, and incontinence. Always adhere to your physician's prescribed dosage and regimen for Mirago S 50 ER; it can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, inflammation of the throat and nasal passages (nasopharyngitis), urinary tract infections, and headaches. Report any persistent or bothersome side effects promptly to your doctor. Before commencing treatment, disclose all current medications and any existing health conditions, including pregnancy or breastfeeding. Individuals with liver or kidney impairment should exercise caution, receiving regular monitoring under their doctor's guidance.
Primary Ingredients of Mirago S 50 Tablet ER
No text provided to rephrase.
Uses of Mirago S 50 Tablet ER
Symptoms indicative of an overactive bladder
Major Benefits of Mirago S 50 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirago S 50 Tablet ER can be administered with or without food, although consistent timing is recommended.
Common Side effects of Mirago S 50 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Mirago S 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirago S 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
How Mirago S 50 Tablet ER works:
Mirago S 50 ER tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 agonist, relaxes bladder muscles by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism, also promoting bladder muscle relaxation. This combined action reduces urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mirago S 50 Tablet ER concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Mirago S 50 Tablet ER use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Mirago S 50 Tablet ER use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Mirago S 50 Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Mirago S 50 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Mirago S 50 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mirago S 50 Tablet ER :
NA
Facts to Know About Mirago S 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |




